DF-006 is a first-in-class, orally administered ALPK1 agonist immunomodulator that potently stimulates local, innate immunity in the liver 1. DF-006 has successfully completed single and multiple ...
BURNABY, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation ...
Adrenomedullin as an immunomodulator of CD14+MerTK+ circulating monocytes in liver failure syndromes
Adrenomedullin is increased in acute liver failure syndromes (ALF and ACLF), and AMBP1 is, on the contrary, reduced, mirroring the severity of the disease expressed by the SOFA score. ADM affects ...
Please provide your email address to receive an email when new articles are posted on . The anti-inflammatory market in dry eye disease is heating up. Cyclosporine brands will battle with each other, ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Psoriasis is a chronic, recurrent and inflammatory skin disorder associated with immune system dysregulation. The abnormal immune response led to accelerated skin cell proliferation, resulting in ...
Approximately 1,670 die a day from some form of cancer; in the United States, around 1.9 million cases of cancer were diagnosed in 2023. Those numbers are staggering, yet not surprising. We have ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback